Updates are available Correction dated 2020-12-10

Article History

Accepted: 29 September 2020

First Online: 7 October 2020

Change Date: 10 December 2020

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s11910-020-01089-5

Compliance with Ethical Standards

:

: Dr. Kazamel received consulting fees from Akcea Therapeutics.Dr. Desnick is a consultant for Alnylam Pharmaceuticals and Recordati Rare Diseases. He has received grants from both entities. He receives royalties for a licensed patent to Alnylam Pharmaceuticals.Dr. Quigley received consulting fees from Alnylam Pharmaceuticals.

: This article does not contain any studies with human or animal subjects performed by any of the authors.